Related Experiment Videos
The effects of protamine on a murine leukemia virus
British Journal of Cancer
|March 1, 1971
Abstract:
THIS STUDY INDICATED THAT: (1) i.p. inoculation of protamine into (Rauscher) leukemic mice increased their X death time, (2) protamine was more toxic for leukemic than normal mice and (3) the in vitro reaction between Rauscher virus and protamine reduced its infectivity for mice.
Insights
Protamine administration extended survival in Rauscher leukemia mouse models. However, protamine exhibited higher toxicity in leukemic mice and reduced Rauscher virus infectivity in vitro.
Area of Science:
- Oncology
- Virology
- Pharmacology
Background:
- Rauscher murine leukemia virus (RMLV) is a retrovirus causing leukemia in mice.
- Protamine is a highly basic protein with potential antiviral and anti-cancer properties.
Purpose of the Study:
- To investigate the therapeutic potential and toxicity of protamine in a murine model of Rauscher leukemia.
- To assess the direct effect of protamine on Rauscher leukemia virus infectivity.
Main Methods:
- Intraperitoneal inoculation of protamine into Rauscher leukemic mice.
- Comparative toxicity assessment of protamine in leukemic versus normal mice.
- In vitro incubation of Rauscher leukemia virus with protamine followed by infectivity assays.
Main Results:
- Protamine administration significantly increased the survival time of leukemic mice.
- Protamine demonstrated greater toxicity in leukemic mice compared to normal mice.
- In vitro reaction between Rauscher leukemia virus and protamine led to a reduction in viral infectivity.
Conclusions:
- Protamine may possess therapeutic benefits in Rauscher leukemia by prolonging survival.
- Careful dose-ranging studies are warranted due to protamine's differential toxicity.
- Protamine's direct antiviral activity against Rauscher leukemia virus is confirmed in vitro.